Abound Wealth Management Catalent, Inc. Transaction History
Abound Wealth Management
- $301 Billion
- Q3 2024
A detailed history of Abound Wealth Management transactions in Catalent, Inc. stock. As of the latest transaction made, Abound Wealth Management holds 39 shares of CTLT stock, worth $2,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39
Previous 39
-0.0%
Holding current value
$2,316
Previous $2.19 Million
7.75%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CTLT
# of Institutions
493Shares Held
161MCall Options Held
286KPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$912 Million0.02% of portfolio
-
Nomura Holdings Inc Tokyo, M011MShares$653 Million1.22% of portfolio
-
State Street Corp Boston, MA7.34MShares$436 Million0.02% of portfolio
-
Barclays PLC London, X04.97MShares$295 Million0.09% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.7B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...